Holen Sie sich die Stockscreener-App
3.17
8.56%
0.25
Handel nachbörslich:
3.16
-0.010
-0.32%
Schlusskurs vom Vortag:
$2.92
Offen:
$3
24-Stunden-Volumen:
43,592
Relative Volume:
0.79
Marktkapitalisierung:
$138.41M
Einnahmen:
$11.51M
Nettoeinkommen (Verlust:
$-101.84M
KGV:
-1.1866
EPS:
-2.6714
Netto-Cashflow:
$-82.98M
1W Leistung:
+0.00%
1M Leistung:
-22.30%
6M Leistung:
-35.83%
1J Leistung:
-53.86%
1-Tages-Spanne:
$3.00
$3.195
1-Wochen-Bereich:
$2.76
$3.195
52-Wochen-Spanne:
$2.76
$8.64
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
3.17 | 127.49M | 11.51M | -101.84M | -82.98M | -2.6714 |
ISRG
Intuitive Surgical Inc
|
464.45 | 163.73B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.34 | 44.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.51 | 36.73B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.00 | 36.12B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
222.85 | 32.70B | 5.40B | 1.49B | 1.78B | 10.12 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Exit Recap: Will Nyxoah SA benefit from AI trendsEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Cantor Fitzgerald Initiates Nyxoah SA(NYXH.US) With Buy Rating, Announces Target Price $11 - 富途牛牛
[20-F] Nyxoah SA Files Annual Report (Foreign Issuer) | NYXH SEC FilingForm 20-F - Stock Titan
Bull Run: Can Nyxoah SA ride the EV waveShare Buyback & Accurate Buy Signal Notifications - baoquankhu1.vn
Retail Trends: Is now the right time to enter Nyxoah SAMarket Risk Analysis & Long-Term Safe Return Strategies - baoquankhu1.vn
Breakout Zone: Is Nyxoah SA a speculative investment2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - MSN
Cantor Fitzgerald Reiterates Overweight Rating for NYXH, Price T - gurufocus.com
Cantor Fitzgerald reiterates Nyxoah stock rating on U.S. launch - Investing.com UK
Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
New Highs: Will Nyxoah SA benefit from rising consumer demandQuarterly Risk Review & Reliable Intraday Trade Plans - baoquankhu1.vn
Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 - marketbeat.com
Nyxoah (ENXTBR:NYXH) Losses Of €90 Million Keep Bearish Cash Runway Concerns In Focus - simplywall.st
Nyxoah Discloses Taub Group’s 10.14% Stake After Threshold Crossing - TipRanks
Publication relating to transparency notifications - GlobeNewswire
Stifel Nicolaus Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
Nyxoah (NYXH) Q4 2025 Earnings Call Transcript - AOL.com
NYXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges By GuruFocus - Investing.com Canada
Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Nyxoah Q4 2025 Earnings Call Transcript - MarketBeat
Nyxoah SA reports results for the quarter ended December 31Earnings Summary - TradingView
NYXH: FDA approval and U.S. launch fueled 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Q4 Earnings Call Highlights - MarketBeat
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
NYXH: Transformative U.S. launch drove 122% revenue growth and strong Q4 momentum - TradingView
Nyxoah Leverages First Full U.S. Sales Quarter to Power Triple-Digit 2025 Revenue Growth - TipRanks
Nyxoah (NASDAQ: NYXH) doubles 2025 revenue as U.S. launch drives growth but losses deepen - Stock Titan
Nyxoah SA Provides Revenue Guidance for the First Quarter and Second Quarter of 2026 - marketscreener.com
Nyxoah SA (NYXH) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - bitget.com
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - news.futunn.com
What is the long term forecast for Nyxoah SA stockWeekly Trade Summary & AI Driven Stock Movement Reports - baoquankhu1.vn
Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result - gurufocus.com
Nyxoah SA expected to post a loss of 53 cents a shareEarnings Preview - tradingview.com
Earnings Preview: Nyxoah SA to Report Financial Results on March 19 - 富途牛牛
Publication relating to transparency notification - GlobeNewswire
Nyxoah price target lowered to EUR 5 from EUR 7 at Baird - MSN
Nyxoah (NYXH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewswire
Trading Recap: Will Nyxoah SA benefit from rising consumer demandShare Buyback & Target Return Focused Picks - baoquankhu1.vn
Will Nyxoah SA benefit from rising consumer demandJuly 2025 Gainers & AI Driven Stock Movement Reports - baoquankhu1.vn
Technical Analysis: Does Nyxoah SA have a competitive edgeJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Aug Ideas: Can Nyxoah SA sustain its profitabilityPortfolio Growth Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 - The Manila Times
Nyxoah SA (NASDAQ:NYXH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Cantor Fitzgerald Upgrades Nyxoah (NASDAQ:NYXH) to "Strong-Buy" - MarketBeat
Nyxoah (NYXH) Expected to Announce Earnings on Thursday - MarketBeat
Nyxoah SA (NASDAQ:NYXH) Short Interest Down 17.8% in February - MarketBeat
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):